NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II study

被引：0

作者：

Gregorc, V. ^{[1
]}

Ceresoli, G. L. ^{[2
]}

Zucali, P. A. ^{[2
]}

De Braud, F. G. ^{[3
]}

Bajetta, E. ^{[4
]}

Santoro, A. ^{[2
]}

Vigano, M. G. ^{[1
]}

Cappio, F. Caligaris ^{[1
]}

Lambiase, A. ^{[5
]}

Bordignon, C. ^{[5
]}

机构：

[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy

[2] Ist Clin Humanitas, Dept Oncol, Milan, Italy

[3] Ist Europeo Oncol, Clin Pharmacol & New Drugs Unit, Milan, Italy

[4] IRCCS Fdn, Ist Nazl Tumori, Dept Oncol, Milan, Italy

[5] MolMed, Clin Dev, Milan, Italy

来源：

EJC SUPPLEMENTS | 2009年 / 7卷 / 02期

关键词：

D O I：

10.1016/S1359-6349(09)71724-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：509 / 509

页数：1

共 50 条

[1] Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM) [J].

Gregorc, V. ;

Ceresoli, G. L. ;

Zucali, P. A. ;

De Braud, F. G. ;

Bajetta, E. ;

Santoro, A. ;

Vigano, M. G. ;

Caligaris-Cappio, F. ;

Lambiase, A. ;

Bordignon, C. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

[2] NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM) [J].

De Vincenzo, F. ;

Rossoni, G. ;

Santoro, A. ;

Gregorc, V. ;

Zucali, P. A. ;

Citterio, G. ;

Simonelli, M. ;

Petrella, G. ;

Caligaris-Cappio, F. ;

Lambiase, A. ;

Bordignon, C. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[3] PHASE II CLINICAL TRIAL OF NGR-HTNF, A NOVEL VASCULAR TARGETING AGENT (VTA), AS SECOND-LINE THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) [J].

Ceresoli, G. L. ;

Gregorc, V. ;

Zucali, P. A. ;

Noberasco, C. ;

Bajetta, E. ;

Santoro, A. ;

Vigano, M. G. ;

Caligaris-Cappio, F. ;

Lambiase, A. ;

Bordignon, C. .

ANNALS OF ONCOLOGY, 2008, 19 :119-119

[4] NGR-hTNF, a novel vascular targeting agent (VTA), as second-line therapy in malignant pleural mesothelioma (MPM): Preliminary results of multicenter phase II study [J].

Gregorc, V. ;

Zucali, P. ;

Ceresoli, G. L. ;

Noberasco, C. ;

Bajetta, E. ;

Santoro, A. ;

Vigano, M. G. ;

Caligaris-Cappio, F. ;

Lambiase, A. ;

Bordignon, C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[5] Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients with hepatocellular carcinoma (HCC) [J].

Santoro, A. ;

Citterio, G. ;

Pressiani, T. ;

De Braud, F. G. ;

Gregorc, V. ;

Rossoni, G. ;

Donadoni, G. ;

Caligaris-Cappio, F. ;

Lambiase, A. ;

Bordignon, C. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

[6] Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC) [J].

Santoro, A. ;

Citterio, G. ;

Pressiani, T. ;

Gregorc, V. ;

Rimassa, L. ;

De Braud, F. G. ;

Rossoni, G. ;

Cappio, F. Caligaris ;

Lambiase, A. ;

Bordignon, C. .

EJC SUPPLEMENTS, 2009, 7 (02) :395-395

[7] NGR-hTNF as second-line treatment in malignant pleural mesothelioma (MPM) [J].

Rossoni, Gilda ;

Gregorc, Vanesa ;

Vigano, Maria Grazia ;

Bulotta, Alessandra ;

Ghio, Domenico ;

Lambiase, Antonio ;

Bordignon, Claudio .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

[8] Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM) [J].

Gregorc, V. ;

Gaafar, R. ;

Favaretto, A. ;

Grossi, F. ;

Jassem, J. ;

Polychronis, A. ;

Bidoli, P. ;

Tiseo, M. ;

O'Brien, M. ;

Shah, R. ;

Taylor, P. ;

Novello, S. ;

Muzio, A. ;

Bearz, A. ;

Badurak, P. ;

Greillier, L. ;

Fontana, F. ;

Colombi, S. ;

Lambiase, A. ;

Bordignon, C. .

EUROPEAN JOURNAL OF CANCER, 2015, 51 :S634-S634

[9] NGR-hTNF Vascular Targeting Agent Oncolytic [J].

Vasitiou, S. ;

Suria, R. .

DRUGS OF THE FUTURE, 2011, 36 (04) :281-285

[10] Phase I study of NGR-hTNF, a vascular targeting agent (VTA), in combination withcisplatin in refractory patients (pts) with solid tumours [J].

Citterio, G. ;

De Braud, F. G. ;

Gregorc, V. ;

De Pas, T. M. ;

Noberasco, C. ;

Boselli, S. ;

Giovannini, M. ;

Cappio, F. Caligaris ;

Lambiase, A. ;

Bordignon, C. .

EJC SUPPLEMENTS, 2009, 7 (02) :129-129

← 1 2 3 4 5 →